Myelodysplastic Syndromes (MDS)

In MDS, either insufficient healthy red cells, white cells, or platelets from the bone marrow causes symptoms including tiredness, regular infections, and easy bruising or bleeding.

Often referred to as a "bone marrow failure disorder," MDS can be either primary—an unknown cause—or secondary—linked to past radiation or chemotherapy. The disease's degree can vary from minor to life-threatening; occasionally it may develop into acute myeloid leukaemia (AML).
Usually, diagnosis calls for bone marrow biopsies, peripheral blood smears, and full blood counts. Chromosomal defects found by genetic testing also direct therapy and prognosis.
Subtype, risk level, and patient condition all affect treatment. Among the options are supportive care including blood transfusions, growth hormones to increase blood cell production, chemotherapy, focused treatment, and, in certain cases, bone marrow or stem cell transplantation.
For those living with MDS, early identification and tailored treatment plans can help control symptoms, slow down development, and increase quality of life.